Carregant...
The potential of PARP inhibitors in neuro-oncology
DNA damaging agents have an integral role in the treatment of brain tumors. Recent advances in our understanding of how cancer cells repair DNA damage have made it possible to consider modification of the DNA damage response as a way in which resistance to radiotherapy and chemotherapy might be over...
Guardat en:
| Publicat a: | CNS Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Future Medicine Ltd
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6176825/ https://ncbi.nlm.nih.gov/pubmed/25054302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns.12.13 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|